Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-27

FDA Approved: MOXIFLOXACIN OPHTHALMIC SOLUTION — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved a generic ophthalmic moxifloxacin solution from Lifestar Pharma LLC under an original ANDA for the treatment of bacterial conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxifloxacin ophthalmic solution (moxifloxacin)

Snippet

ORIG AP for MOXIFLOXACIN OPHTHALMIC SOLUTION (MOXIFLOXACIN)